Sunday, October 20, 2024

Week in Review 42/24



 

Welcome and thanks for reading!

In this review, I will make a summary of important and interesting news and events over the last week related to my portfolio holdings. Also, I will put together some interesting articles from other websites that caught my attention during the past week.



Received Dividends:



October 14, 2024


  • €19.96 – Illinois Tool Works Inc. (ITW)


October 15, 2024


  • €24.03 – Cardinal Health, Inc. (CAH)
  • €25.76 – Main Street Capital (MAIN)
  • €40.76 – W. P. Carey Inc. (WPC)
  • €33.64 – Realty Income Corporation (O)
  • €56.57 – BCE Inc. (BCE)
  • €28.21 – Algonquin Power & Utilities Corp. (AQN)


October 18, 2024


  • €50.83 – Tele2 AB (TEL2)
  • €19.67 – Bank OZK (OZK)



Week 42: Total net dividends €299.44


Dividend income is reported after the deduction of taxes. Check more at my Monthly Dividend sheet.



Portfolio Holdings News:



October 14, 2024



October 15, 2024


  • Johnson & Johnson (JNJ) Reports Q3 2024 Results; JNJ reports second quarter Non-GAAP EPS of $2.42, 9% below last year's result but $0.21 more than expected. Revenue of $22.5 billion beats analyst estimates by $330 million and increased 5.4% versus the same quarter last year. Management guides Operational Sales between $89.4B – $89.8B and Adjusted EPS (Diluted) between $9.88 – $9.98.



October 16, 2024


  • UPM-Kymmene Corporation Lowers Its Outlook; UPM lowers its outlook for 2024 and releases its preliminary Q3 2024 results. Comparable EBIT in Q4 2024 is expected to be on similar level or increase from Q4 2023 (EUR 323 million). Therefore, UPM’s comparable EBIT in full-year 2024 is expected to be on similar level or increase from 2023. Earlier, UPM expected its full-year 2024 comparable EBIT to increase from 2023, and its H2 2024 comparable EBIT to be higher than in H1 2024.



  • Kinder Morgan, Inc. (KMI) Reports Third Quarter 2024 Financial Results; KMI reports third quarter Non-GAAP EPS of $0.25 , flat with last year and $0.02 less than expected. Revenue fell 5.6% to $3.69 billion, which was $360 million less than expected. Distributable cash flow (DCF) per share of $0.49, flat to the third quarter of 2023. Management budgeted 2024 DCF of $5 billion ($2.26 per share), Adjusted EBITDA of $8.16 billion, both up 8% versus 2023.



  • Crown Castle Inc. (CCI) Reports Third Quarter 2024 Results; CCI reports Q3 FFO of $1.84, beating analyst estimates by $0.14 and increased 4% year-over-year. Net revenue of $1.65 billion, exceeding the average analyst estimate of $1.64 billion, climbed from $1.63 billion in the previous quarter slipped from $1.67 billion a year ago. Management reaffirmed its 2024 adjusted FFO per share guidance of $6.91-$7.02.


October 17, 2024


  • Nordea Bank Abp (NDA-FI.HE) Reports Third-Quarter Results 2024; NDA reports Q3 diluted earnings per share of €0.36, beating analyst estimates by €0.0,1 but 5% below last year's result. Total operating income grew 2% to €3,014 million beating estimates by €37 million. Operating profit fell 5% to €1,634 million, €57 million more than expected. CET1 ratio was 15.8%, compared with 17.5% at the end of the prior quarter. Management guides return on equity of above 16%.


  • Bank OZK (OZK) Announces Third Quarter 2024 Earnings; OZK reports Q3 GAAP EPS of $1.55, 4% above last year's result and $0.01 more than expected. Revenue of $423 million was in line with analyst estimates and increased 7.6% year-over-year. OZK's provision for credit losses decreased to $46.4M from $49.0M in the previous quarter and increased from $44.0M a year ago. Book value per common share was $46.31 at September 30, 2024, a $5.96 increase from $40.35 at September 30, 2023.


October 18, 2024


  • The Procter & Gamble Company (PG) Announces Fiscal Year 2025 First Quarter Results; PG reports Q1 Non-GAAP EPS of $1.93, beating analyst estimates by $0.03 and increased 5% year-over-year. Revenue fell 0.6% to $21.74 billion, missing analyst estimates by $240 million. Management maintained its fiscal 2025 diluted net earnings per share growth to be in the range of 10% to 12% versus fiscal 2024 diluted net EPS of $6.02 and also maintained its fiscal 2025 core earnings per share growth to be in the range of five to seven percent versus fiscal 2024 core EPS of $6.59. Management continues to expect adjusted free cash flow productivity of 90% and expects to pay around $10 billion in dividends and to repurchase $6 to $7 billion of common shares in fiscal 2025.



  • Ally Financial Inc. (ALLY) Reports Third Quarter 2024 Financial Results; ALLY reports Non-GAAP EPS of $0.95, up 15% versus prior year and $0.43 ahead of estimates. Revenue of $2.06 billion beats analyst estimates by $30 million and increased 1% versus the same quarter last year. PCL increased $137 million year over year to $645 million. CET1 of 9.8% up 20 bps quarter over quarter.



Articles that caught my attention:





Thanks for stopping by!


Posted by
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)